His main research concerns Pathology, Internal medicine, Myocardial infarction, Vascular disease and Cardiology. The study incorporates disciplines such as Inflammation, Artery, Intravascular ultrasound and Stenosis in addition to Pathology. His Artery study incorporates themes from Matrix metalloproteinase and Femoral artery.
Internal medicine and Endocrinology are frequently intertwined in his study. His work carried out in the field of Myocardial infarction brings together such families of science as Surgery, Ligation, Sudden death, Heart failure and Disease. His study in Vascular disease is interdisciplinary in nature, drawing from both Arteriosclerosis, Restenosis, Stroke, Atheroma and Lumen.
His scientific interests lie mostly in Internal medicine, Cardiology, Pathology, Myocardial infarction and Carotid endarterectomy. His research in Internal medicine intersects with topics in Endocrinology and Surgery. His Cardiology study integrates concerns from other disciplines, such as Stroke and Restenosis.
The Pathology study combines topics in areas such as Inflammation, Matrix metalloproteinase and Vascular disease. His Myocardial infarction research includes elements of Reperfusion injury and Ischemia. His studies deal with areas such as Endarterectomy and Proportional hazards model as well as Carotid endarterectomy.
Gerard Pasterkamp focuses on Internal medicine, Cardiology, Myocardial infarction, Disease and Carotid endarterectomy. His study explores the link between Internal medicine and topics such as Endocrinology that cross with problems in Receptor. His work investigates the relationship between Cardiology and topics such as Inflammation that intersect with problems in Endothelium.
His Myocardial infarction research is multidisciplinary, incorporating elements of Stroke and Vulnerable plaque. His studies in Disease integrate themes in fields like Quantitative trait locus, Endothelial dysfunction, Preeclampsia and Intensive care medicine. Gerard Pasterkamp has researched Carotid endarterectomy in several fields, including Proportional hazards model and Pathology.
Gerard Pasterkamp spends much of his time researching Internal medicine, Myocardial infarction, Disease, Inflammation and Stroke. His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology and Cardiology. His Myocardial infarction study combines topics in areas such as Relative risk and Early discharge.
The various areas that he examines in his Disease study include Biomarker, Hematology, Anemia and Cohort. His Inflammation study is focused on Immunology in general. Gerard Pasterkamp interconnects Calcification, Pathology and Cvd risk in the investigation of issues within Carotid endarterectomy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells.
Circulation (2003)
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.
Ruenn Chai Lai;Fatih Arslan;May May Lee;Newman Siu Kwan Sze.
Stem Cell Research (2010)
Genetic studies of body mass index yield new insights for obesity biology
Adam E. Locke;Bratati Kahali;Sonja I. Berndt;Anne E. Justice.
Faculty of Health; Institute of Health and Biomedical Innovation (2015)
From Vulnerable Plaque to Vulnerable Patient
Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells.
Circulation (2003)
Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury
Fatih Arslan;Ruenn Chai Lai;Ruenn Chai Lai;Mirjam B. Smeets;Lars Akeroyd.
Stem Cell Research (2013)
Extracellular vesicles for drug delivery.
Pieter Vader;Emma A Mol;Gerard Pasterkamp;Raymond M Schiffelers.
Advanced Drug Delivery Reviews (2016)
Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium.
Leo Timmers;Sai Kiang Lim;Fatih Arslan;Jeffrey S. Armstrong.
Stem Cell Research (2008)
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard.
European Heart Journal (2020)
Characterization of Plaque Components With Intravascular Ultrasound Elastography in Human Femoral and Coronary Arteries In Vitro
C. L. De Korte;G. Pasterkamp;A. F. W. Van Der Steen;H. A. Woutman.
Circulation (2000)
Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.
Leo Timmers;José P.S. Henriques;Dominique P.V. de Kleijn;J. Hans DeVries.
Journal of the American College of Cardiology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Utrecht University
Utrecht University
Utrecht University
Leiden University Medical Center
University of Leicester
The University of Texas Health Science Center at Houston
Utrecht University
Stanford University
Guy's and St Thomas' NHS Foundation Trust
Boston Children's Hospital
Radboud University Nijmegen
New Economic School
Linköping University
University of Minnesota
Kyoto University
Chinese Academy of Sciences
University of Helsinki
University of Florida
University of Florida
Concordia University
University of Rome Tor Vergata
University of Calgary
University at Albany, State University of New York
Ghent University Hospital
The University of Texas MD Anderson Cancer Center
Stanford University